Clinical Trial Update: A Phase 1, Double-Blind, Randomized, Single Dose Escalation Safety Study of Intra-articular OP-1 in Subjects With Osteoarthritis of the Knee [Phase 1]

View source ↗

Summary

This document reports the completion of a Phase 1, double-blind, randomized, single-dose-escalation safety study evaluating intra-articular OP-1 in knee osteoar…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis of the Knee

Drugs mentioned

• OP-1 (osteogenic protein-1)

Snippet

Sponsor: Stryker Biotech | Conditions: Osteoarthritis of the Knee | Phase 1 | Status: COMPLETED